Bio-defense Market: Global Opportunity Analysis and Industry Forecast 2020–2027
A08413 | Pages: NA | Jun 2021 | 139 Views | | |
Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Bio-defense Market: Global Opportunity Analysis and Industry Forecast 2020–2027
Request Now !Bio-defense accounts for the use of various medical procedures that help in protecting individuals against bioterrorism, which involves not only drugs and vaccinations but also research and various health preparations for the population for defending themselves against such biological attacks. Bio-defenses are a combination of different systems and processes, which are put together in a place by bioscience laboratories, agricultural managers, customs agents, and other professionals to prevent the use of dangerous pathogens and toxins. Examples of these include the regulations that are imposed on the research carried out on certain pathogens, or preparatory plans for the case of a hostile disease outbreak. To build and maintain a successful bio-defense system, laboratories should have a mechanism methodology for the investigation of the outbreak and also a mechanism to prevent a biological attack. This mechanism should comprise primitive, secondary, and tertiary level prevention from the biological attacks.
Market scope and structure analysis:
Report Metric | Details |
Market size available for years | 2019–2027 |
Base year considered | 2019 |
Forecast period | 2020–2027 |
Forecast unit | Value (USD) |
Segments covered | Product, Application, End Users |
Regions covered | North America (the U.S. and Canada), Europe (Germany, the UK, France, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), Latin America (Brazil, Mexico, and rest of LATAM), and the Middle East and Africa |
Companies covered | Emergent Bio-Solutions, Inc., Xoma Corporation, PharmAthene, Inc., SIGA Technologies, Inc., Dynavax Technologies Corporation, Elusys Therapeutics, Inc., Cleveland Biolabs, Ichor Medical Systems, Dynport Vaccine Company LLC, Achaogen, Inc., Bavarian Nordic, Nano therapeutics, Inc., and Alnylam Pharmaceuticals, Inc. |
COVID-19 scenario analysis:
- Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19.
- Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
- Attributed to such factors, COVID-19 is expected to have a significant impact on the market.
Top impacting factors: Market scenario analysis, trends, drivers, and impact analysis
Governments are taking various initiatives to enhance the readiness against chemical, biological, nuclear and radiological threats, advancements, and adoption through the technological perspective, gene chips being produced for pathogen detection in forensic division, database management systems, nanotechnology, and advanced detector hardware in bio-defense drug development. These are the major factors affecting the bio-defense market positively.
There has been a rise in the frequency of infectious diseases, such as influenza, that has spread a lot of awareness and encouraged pharmaceutical companies to work on R&D for such biological threats. Various programs are also conducted to improvise the scientific research of infectious diseases and create awareness within the public and encourage the population to use public health and be prepared for such biological attacks.
Additionally, the congenital Zika virus infection incidence has helped to boost the investments in the field of bio-defense. Nuclear or radiation weapons are capable of destruction due to their harmful effects, such as radiations, and cause damage equivalent to explosive bombs. To reduce the risk of bio attacks, governments across the world provide funding for medical countermeasures against the attacks to help the market growth positively. Moreover, there has been significant growth in the investments by governments in R&D in North America & European countries. Governments of the Asia-Pacific and Latin American countries are also working on new and favorable initiatives to develop their bio-defense systems. The upgrades in the technological aspect in the biotechnology sector in North America and Europe also contributes to the market growth.
On the other hand, the funding provided for manufacturing vaccines against bioterrorism attacks by authorities in developing and underdeveloped economies is considerably low and hampers the bio-defense market growth.
New product launches and acquisitions to boost the market
On August 8th, 2018, Emergent BioSolutions, Inc. took possession of PaxVax Holding Company Ltd., a developer and manufacturer of vaccines to fight against infectious diseases. In 2018, the U.S. government announced National Bio-defense Strategy and Implementation Plan, the National Defense Strategy, and the National Counterterrorism Strategy, the National Security Strategy, and the National Counter WMD Strategy to provide bio-defense and bio-security to the country. On January 27th, 2017, Emergent BioSolutions Inc. got an approval from the German Federal Ministry of Health, which allowed it to market BioThrax, which was an Anthrax vaccine.
Surge in usage in government and military applications
The major consumers of the bio-defense market are the military and governments of any country. As the governments are closely looking upon the current and future policies and the activities to understand the bio-security and bio-defense threats & preventions, various pharmaceutical companies operating in the bio-defense market have considerable opportunities to expand and be prepared for any bioterrorism.
Key segments covered:
Segments | Sub-segments |
Product |
|
Application |
|
End Users |
|
Key benefits of the report:
- This study presents the analytical depiction of the bio-defense market along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the bio-defense market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the bio-defense market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the bio-defense market.
- The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the bio-defense market research report:
- Which are the leading market players active in the market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What are the projections for the future that would help in taking further strategic steps?
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Bio-defense Market: Global Opportunity Analysis and Industry Forecast 2020–2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Featured Reports
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers